Free Trial

ENDRA Life Sciences (NDRA) Earnings Date, Estimates & Call Transcripts

ENDRA Life Sciences logo
$4.76 -0.10 (-1.95%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ENDRA Life Sciences Earnings Summary

ENDRA Life Sciences announced Q2 2025 earnings on August 14, 2025, reporting an EPS of -$1.71, which topped analysts' consensus estimates of -$2.27 by $0.56. With a trailing EPS of -$33.89, ENDRA Life Sciences' earnings are expected to grow next year, from ($47.46) to ($15.38) per share.

Latest Q2
Earnings Date
Aug. 14Estimated
Consensus EPS
(Aug. 14)
-$2.27
Actual EPS
(Aug. 14)
-$1.71 Beat By $0.56
Get ENDRA Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NDRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENDRA Life Sciences Analyst EPS Estimates

Current Year EPS Consensus Estimate
($47.46) EPS
Next Year EPS Consensus Estimate
($15.38) EPS

ENDRA Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025-$2.27-$1.71+$0.56-$1.71--
3/31/2025Q4 2024-$4.10-$9.40 -$5.30-$20.78--
8/14/2024Q2 2024-$122.50-$140.00 -$17.50-$0.08--
5/14/2024Q1 2024--$22,750.00--$0.26--
3/28/2024Q4 2023--$14,875.00--$0.17--
11/14/2023Q3 2023--$700.00--$0.40--

ENDRA Life Sciences Earnings - Frequently Asked Questions

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earning data on Thursday, August 14, 2025. Learn more on NDRA's earnings history.

In the previous quarter, ENDRA Life Sciences (NASDAQ:NDRA) reported ($1.71) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.27) by $0.56. Learn more on analysts' earnings estimate vs. NDRA's actual earnings.

ENDRA Life Sciences (NASDAQ:NDRA) has a recorded net income of -$11.51 million. NDRA has generated -$33.89 earnings per share over the last four quarters.

ENDRA Life Sciences' earnings are expected to grow from ($47.46) per share to ($15.38) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NDRA) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners